EP18 Use of anakinra for haemophagocytic lymphohistiocytosis in adults

Luke Sammut(University Hospital Southampton NHS Foundation Trust), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Saerrah Murryam(University Hospital Southampton NHS Foundation Trust), Natalie Vincent(University Hospital Southampton NHS Foundation Trust), Brian Davidson(University Hospital Southampton NHS Foundation Trust)
Lara D. Veeken
April 1, 2020
10.1093/rheumatology/keaa109.017
Cited by 4

Related Papers

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
|The Lancet|2021|324